R&D Systems代理720-IC-050 Recombinant Human ICAM-1/CD54 Fc Chimera Protein, CF (50 UG)

2025-06-27

货号:720-IC-050

品牌:R&D Systems

规格:50ug

目录价:¥3130.00

市场价格:¥2504.00

会员价格:¥2504.00

  • 到货时间:3~4周

    金山科研平台,产品价格货期咨询微信:jinshanbio Source:Mouse myeloma cell line, NS0-derived Accession #:CAA30051 N-terminal Sequence Analysis:No results obtained: Gln28 predicted Structure:Disulfide-linked homodimer Purity:>95%, by SDS-PAGE under reducing conditions and visualized by silver stain. Predicted Molecular Mass:76 kDa (monomer) SDS-PAGE:110-125 kDa, reducing conditions Activity:Measured by the ability of the immobilized protein to support the adhesion of PMA-stimulated HSB2 human peripheral blood acute lymphoblastic leukemia cells.When 5 x 104 cells/well are added to recombinant human ICAM Fc Chimera coated plates (12.5 µg/mL with 100 µL/well), >60% will adhere after PMA 1 hour incubation at 37 °C.Optimal dilutions should be determined by each laboratory for each application. Formulation:Lyophilized from a 0.2 µm filtered solution in PBS.See Certificate of Analysis for details. Molecule Information: ICAM-1/CD54 Long Name: Intercellular Adhesion Molecule 1 Aliases: CD54 Entrez Gene IDs: 3383 (Human); 15894 (Mouse); 25464 (Rat) Background: ICAM-1/CD54 Intercellular adhesion molecule 1 (ICAM-1), also known as CD54, binds the leukocyte integrins LFA-1 and Mac-1. ICAM-1 expression is weak on leukocytes, epithelial and resting endothelial cells, as well as some other cell types, but expression can be stimulated by IFN-gamma, TNF-alpha, IL-1 beta and LPS. Soluble ICAM-1 is found in a biologically active form in serum, probably as a result of proteolytic cleavage from the cell surface.

    © 金山科研平台是专业的授权总代理区域代理经销平台。
    © 如需询价,请加客服QQ:1749072012 、客服微信:jinshanbio,或发送邮件到1749072012@qq.com
    © 平台为生命科学研究相关领域提供一站式耗材试剂仪器解决方案和采购服务,数据资源基于CC协议。
    © 本文地址:https://www.16ao.com/thread-138246.htm
    © R&D Systems代理720-IC-050 Recombinant Human ICAM-1/CD54 Fc Chimera Protein, CF (50 UG),产品报价联系微信jinshanbio
  • 产品询价需求提交
    产品询价请加微信:jinshanbio
    返回